The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
–
It’s a timely moment to weigh the utility of risk-prediction tools. On one hand, the PREVENT calculator is only just making its way into clinical practice — it was added to blood pressure and cholesterol guidelines in the past year.
On the other hand, “the use of calcium scores has been exploding” as CAC scans have become more affordable and accessible, said Nilay Shah, senior author on the study and assistant professor of medicine in the cardiology division at Northwestern University Feinberg School of Medicine.
–
Doctors say there are two main types of risk from these kinds of full-body scans. Healthy bodies commonly contain lumps, scars and masses that are not harmful.
False positives can lead to biopsies, extensive monitoring and, possibly, unnecessary surgeries, said Dr. Sameer Ansari, a diagnostic and interventional neuroradiologist at Northwestern Medicine.
–
“There are a range of systemic health benefits of GLP-1 medications that are linked to their anti-inflammatory properties, metabolic enhancement and mechanical benefits,” said Dr. Robert Kushner, a founder of the American Board of Obesity Medicine and professor emeritus at Northwestern University Feinberg School of Medicine.
While several benefits beyond weight loss are well established, others remain unproven.
–
Northwestern Medicine oncologist Dr. Deva Mahalingam discusses a newly approved pancreatic cancer drug, how it differs from traditional chemotherapy and what it could mean for patients.
–
Dr. Ian Grant, behavioral neurologist at Northwestern Medicine’s Cognitive Neurology & Alzheimer’s Disease Center, joins Bob Sirott to talk about a blood test that can detect Alzheimer’s disease, which was recently approved by the FDA.
He explains how similar tests are used at Northwestern and how doctors can use this test to personalize treatment plans.
–
The Food and Drug Administration on Wednesday approved a groundbreaking pancreatic cancer drug that experts predict will transform treatment for the notoriously deadly disease.
Dr. Deva Mahalingam, a professor of medicine at Northwestern specializing in pancreatic cancer, says his team was eagerly awaiting the approval. He calls it a “fundamental change” in how we think about pancreatic cancer using targeted therapy.
–
When the temperature heats up, so do emergency rooms, according to a massive study of Chicago hospital and urgent care records.
“When there’s heat, there’s a much higher likelihood of people having external injuries, as well as complications of certain conditions, specifically those related to kidney disorders or things like exacerbations of drug effects, like cannabinoids,” said study senior author Dr. Abel Kho, an internal medicine professor at Northwestern.
–
The Lindsay Clancy murder trial has put a spotlight on psychiatric medications and postpartum mental health, especially postpartum psychosis.
Northwestern University professor of Medical Social Sciences Darius Tandon said postpartum psychosis affects about one to two individuals for every 1,000; significantly rarer than postpartum depression, which affects 10-20% of new mothers.
–
Dr. Victoria Weston, MD, Associate Chief Medical Officer, Northwestern Medicine Immediate Care, joins John Williams to talk about Moderna and Merck saying an experimental vaccine prevented the return and spread of cancer in high-risk melanoma patients, a new weight loss drug that may burn fat without muscle loss, and what we should know about flu and COVID shots this fall.
–
In 2026, Illinois expanded its infertility insurance coverage mandate, requiring group health plans that include pregnancy benefits to cover infertility treatments, regardless of employer size.
“Illinois has a really progressive mandate,” said Dr. Emily Jungheim, a Professor of Obstetrics and Gynecology, and a reproductive endocrinologist at Northwestern Medicine. Illinois’ fertility mandate is now one of the strongest in the country, which Jungheim calls “game changing.”